AstraZeneca and Daiichi Sankyo to jointly develop another new cancer treatment

30-07-2020

Muireann Bolger

AstraZeneca and Daiichi Sankyo to jointly develop another new cancer treatment

Fotonen / iStockphoto.com

Biopharmaceutical company AstraZeneca has struck a deal with Japanese pharmaceutical company Daiichi Sankyo to jointly develop and market a new medicine to treat lung, breast and other cancers.


Astrazeneca, Daiichi Sankyo, cancer, TROP2, treatment, medicine, Enhertu, DS-1062, worldwide, global,

LSIPR